Mauna Kea Technologies (LTS:0P5I) Debt-to-EBITDA : -1.84 (As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Mauna Kea Technologies Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Mauna Kea Technologies's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €16.37 Mil. Mauna Kea Technologies's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €13.40 Mil. Mauna Kea Technologies's annualized EBITDA for the quarter that ended in Dec. 2023 was €-16.23 Mil. Mauna Kea Technologies's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was -1.83.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Mauna Kea Technologies's Debt-to-EBITDA or its related term are showing as below:

LTS:0P5I' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -20.38 Med: -1.05 Max: -0.25
Current: -20.38

During the past 13 years, the highest Debt-to-EBITDA Ratio of Mauna Kea Technologies was -0.25. The lowest was -20.38. And the median was -1.05.

LTS:0P5I's Debt-to-EBITDA is ranked worse than
100% of 435 companies
in the Medical Devices & Instruments industry
Industry Median: 1.26 vs LTS:0P5I: -20.38

Mauna Kea Technologies Debt-to-EBITDA Historical Data

The historical data trend for Mauna Kea Technologies's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mauna Kea Technologies Debt-to-EBITDA Chart

Mauna Kea Technologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-EBITDA

Get a 7-Day Free Trial

-1.29

-2.36

-2.56

-2.94

-20.38

Mauna Kea Technologies Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-EBITDA	Get a 7-Day Free Trial															-2.76	-2.48	-3.67	2.24	-1.84

Competitive Comparison of Mauna Kea Technologies's Debt-to-EBITDA

For the Medical Devices subindustry, Mauna Kea Technologies's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mauna Kea Technologies's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Mauna Kea Technologies's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Mauna Kea Technologies's Debt-to-EBITDA falls into.

Mauna Kea Technologies Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Mauna Kea Technologies's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(16.372	+	13.401)	/	-1.461
	=	-20.38

Mauna Kea Technologies's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(16.372	+	13.401)	/	-16.226
	=	-1.83

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Dec. 2023) EBITDA data.

Mauna Kea Technologies (LTS:0P5I) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Mauna Kea Technologies Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Mauna Kea Technologies's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Mauna Kea Technologies (LTS:0P5I) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Mauna Kea Technologies SA (LTS:0P5I) » Definitions » Debt-to-EBITDA

Comparable Companies

Traded in Other Exchanges

ALMKT:France 1MK:Germany

Address

9, rue d'Enghien, Paris, FRA, 75010

Website

https://www.maunakeatech.com

Mauna Kea Technologies SA is a medical device corporation. It is engaged in designing, developing, and marketing an imaging platform used to view tissues at a cellular level, in real-time, during standard procedures. The firm operates in the business segment of Endomicroscopy. The group's technological platform is Cellvizio which helps physicians to detect early-stage pathologies more accurately and make therapeutic decisions. It generates revenue from the sales of Cellvizio products and accessories used for medical diagnostics, research, and related services. The company sells its products in France and internationally, of which the majority of the revenue is derived from America.

Mauna Kea Technologies (LTS:0P5I) Headlines

No Headlines